1139 related articles for article (PubMed ID: 20471303)
21. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
Montero P; Milara J; Roger I; Cortijo J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
[TBL] [Abstract][Full Text] [Related]
22. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
23. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
Morgan EL; Macdonald A
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
[TBL] [Abstract][Full Text] [Related]
24. The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.
Geiger JL; Grandis JR; Bauman JE
Oral Oncol; 2016 May; 56():84-92. PubMed ID: 26733183
[TBL] [Abstract][Full Text] [Related]
25. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
[TBL] [Abstract][Full Text] [Related]
26. Expression of the JAK and STAT superfamilies in human meningiomas.
Magrassi L; De-Fraja C; Conti L; Butti G; Infuso L; Govoni S; Cattaneo E
J Neurosurg; 1999 Sep; 91(3):440-6. PubMed ID: 10470819
[TBL] [Abstract][Full Text] [Related]
27. Systems biology of JAK/STAT signalling.
Pfeifer AC; Timmer J; Klingmüller U
Essays Biochem; 2008; 45():109-20. PubMed ID: 18793127
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
29. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
Liu J; Kern JA
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
[TBL] [Abstract][Full Text] [Related]
30. Jaks and cytokine receptors--an intimate relationship.
Haan C; Kreis S; Margue C; Behrmann I
Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817
[TBL] [Abstract][Full Text] [Related]
31. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.
Cai B; Cai JP; Luo YL; Chen C; Zhang S
Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437
[TBL] [Abstract][Full Text] [Related]
32. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
33. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
Tao W; Wen F; Zhang H; Liu G
Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
[TBL] [Abstract][Full Text] [Related]
34. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
35. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.
Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024
[TBL] [Abstract][Full Text] [Related]
36. Targeting JAK kinase in solid tumors: emerging opportunities and challenges.
Buchert M; Burns CJ; Ernst M
Oncogene; 2016 Feb; 35(8):939-51. PubMed ID: 25982279
[TBL] [Abstract][Full Text] [Related]
37. Mast cell homeostasis and the JAK-STAT pathway.
Morales JK; Falanga YT; Depcrynski A; Fernando J; Ryan JJ
Genes Immun; 2010 Dec; 11(8):599-608. PubMed ID: 20535135
[TBL] [Abstract][Full Text] [Related]
38. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
Venugopal S; Bar-Natan M; Mascarenhas JO
Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
[TBL] [Abstract][Full Text] [Related]
39. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
